147 related articles for article (PubMed ID: 36262502)
21. Cardiotoxicity of 5-flourouracil: two case reports.
Tutkun A; Inanli S; Caymaz O; Ayanoğlu E; Duman D
Auris Nasus Larynx; 2001 Apr; 28(2):193-6. PubMed ID: 11240331
[TBL] [Abstract][Full Text] [Related]
22. Myocardial Ischemia Induced by 5-Fluorouracil: A Prospective Electrocardiographic and Cardiac Biomarker Study.
Dyhl-Polk A; Schou M; Vistisen KK; Sillesen AS; Serup-Hansen E; Faber J; Klausen TW; Bojesen SE; Vaage-Nilsen M; Nielsen DL
Oncologist; 2021 Mar; 26(3):e403-e413. PubMed ID: 32959474
[TBL] [Abstract][Full Text] [Related]
23. Fluoropyrimidine-Associated Cardiotoxicity: A Retrospective Case-Control Study.
Raber I; Warack S; Kanduri J; Pribish A; Godishala A; Abovich A; Orbite A; Dommaraju S; Frazer M; Peters ML; Asnani A
Oncologist; 2020 Mar; 25(3):e606-e609. PubMed ID: 32162823
[TBL] [Abstract][Full Text] [Related]
24. Ventricular fibrillation cardiac arrest due to 5-fluorouracil cardiotoxicity.
Fradley MG; Barrett CD; Clark JR; Francis SA
Tex Heart Inst J; 2013; 40(4):472-6. PubMed ID: 24082383
[TBL] [Abstract][Full Text] [Related]
25. Coronary vasospasm with myocardial stunning in a patient with colon cancer receiving adjuvant chemotherapy with FOLFOX regimen.
Cerny J; Hassan A; Smith C; Piperdi B
Clin Colorectal Cancer; 2009 Jan; 8(1):55-8. PubMed ID: 19203898
[TBL] [Abstract][Full Text] [Related]
26. Fluoropyrimidine-associated cardiotoxicity: revisited.
Saif MW; Shah MM; Shah AR
Expert Opin Drug Saf; 2009 Mar; 8(2):191-202. PubMed ID: 19309247
[TBL] [Abstract][Full Text] [Related]
27. Cardiotoxicity of 5-fluorouracil.
Alter P; Herzum M; Soufi M; Schaefer JR; Maisch B
Cardiovasc Hematol Agents Med Chem; 2006 Jan; 4(1):1-5. PubMed ID: 16529545
[TBL] [Abstract][Full Text] [Related]
28. Incidence and risk markers of 5-fluorouracil and capecitabine cardiotoxicity in patients with colorectal cancer.
Dyhl-Polk A; Vaage-Nilsen M; Schou M; Vistisen KK; Lund CM; Kümler T; Appel JM; Nielsen DL
Acta Oncol; 2020 Apr; 59(4):475-483. PubMed ID: 31931649
[No Abstract] [Full Text] [Related]
29. 5-fluorouracil-induced coronary vasospasm.
Shoemaker LK; Arora U; Rocha Lima CM
Cancer Control; 2004; 11(1):46-9. PubMed ID: 14749623
[TBL] [Abstract][Full Text] [Related]
30. Coronary vasospasm secondary to 5-Fluorouracil and its management: case report.
Yildirim M; Parlak C; Sezer C; Eryilmaz R; Kaya C; Yildiz M
Eurasian J Med; 2011 Apr; 43(1):54-6. PubMed ID: 25610161
[TBL] [Abstract][Full Text] [Related]
31. 5-fluorouracil and cardiotoxicity: a review.
Sara JD; Kaur J; Khodadadi R; Rehman M; Lobo R; Chakrabarti S; Herrmann J; Lerman A; Grothey A
Ther Adv Med Oncol; 2018; 10():1758835918780140. PubMed ID: 29977352
[TBL] [Abstract][Full Text] [Related]
32. Management of Fluoropyrimidine-Induced Cardiac Adverse Outcomes Following Cancer Treatment.
Rajaeinejad M; Parhizkar-Roudsari P; Khoshfetrat M; Kazemi-Galougahi MH; Mosaed R; Arjmand R; Mohsenizadeh SA; Arjmand B
Cardiovasc Toxicol; 2024 Feb; 24(2):184-198. PubMed ID: 38324115
[TBL] [Abstract][Full Text] [Related]
33. The Incidence, Risk Factors, and Outcomes With 5-Fluorouracil-Associated Coronary Vasospasm.
Zafar A; Drobni ZD; Mosarla R; Alvi RM; Lei M; Lou UY; Raghu VK; Murphy SP; Jones-O'Connor M; Hartmann S; Gilman HK; Weekes CD; Clark JR; Clark J; Blaszkowsky L; Tavares E; Neilan TG
JACC CardioOncol; 2021 Mar; 3(1):101-109. PubMed ID: 33817666
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis and Management of a Patient With 5-Fluorouracil-Induced ST Elevation and Nonsustained Ventricular Tachycardia as a Late Presentation of Cardiotoxicity and Successful 5-Fluorouracil Rechallenge.
Medepalli LC; Mahmood TS; Liberman H; Medepalli AM; Bagwell TW
Cureus; 2022 Oct; 14(10):e30489. PubMed ID: 36415417
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of Heart-Type Fatty Acid-Binding Protein and Myocardial Performance Index for Early Detection of 5-Fluorouracil Cardiotoxicity.
Turan T; Agac MT; Aykan AÇ; Kul S; Akyüz AR; Gökdeniz T; Gül İ; Cengiz E; Boyacı F; Erkan H; Akdemir R; Celik S
Angiology; 2017 Jan; 68(1):52-58. PubMed ID: 26980771
[TBL] [Abstract][Full Text] [Related]
36. A case of 5-fluorouracil cardiotoxicity simulating acute myocardial infarction.
Mizuno Y; Hokamura Y; Kimura T; Kimura Y; Kaikita K; Yasue H
Jpn Circ J; 1995 May; 59(5):303-7. PubMed ID: 7596036
[TBL] [Abstract][Full Text] [Related]
37. The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasm.
Zafar A; Drobni ZD; Lei M; Gongora CA; Quinaglia T; Lou UY; Mosarla R; Murphy SP; Jones-O'Connor M; Mahmood A; Hartmann S; Gilman HK; Weekes CD; Nipp R; Clark JR; Clark JW; Blaszkowsky LS; Tavares E; Neilan TG
PLoS One; 2022; 17(4):e0265767. PubMed ID: 35390017
[TBL] [Abstract][Full Text] [Related]
38. Failure of oral nitrate and calcium channel blocker therapy to prevent 5-fluorouracil-related myocardial ischemia: a case report.
Akpek G; Hartshorn KL
Cancer Chemother Pharmacol; 1999; 43(2):157-61. PubMed ID: 9923822
[TBL] [Abstract][Full Text] [Related]
39. [Cardiotoxicity of 5-fluorouracil: report of 6 cases].
Timour Q; Lombard-Bohas C; Slim R; Barel C; Bui-Xuan B; Tabib A; Bricca G; Malonne H; Vial T; Iordescu D; Descotes J
Therapie; 2002; 57(3):302-6. PubMed ID: 12422546
[TBL] [Abstract][Full Text] [Related]
40. 5-Fluorouracil-related Cardiotoxicity; Findings From Five Randomized Studies of 5-Fluorouracil-based Regimens in Metastatic Colorectal Cancer.
Abdel-Rahman O
Clin Colorectal Cancer; 2019 Mar; 18(1):58-63. PubMed ID: 30470591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
